IT’S THAT TIME of the year again when the spread of influenza reaches fever pitch. And with the flu season on us, can medication to treat it be far behind? Data from Pharmarack, an integrated B2B healthcare platform, reveals that sales of antiviral drug Oseltamivir, commonly known as Tamiflu, has seen healthy growth in the past three months. In December 2022, at least 227,000 units of the drug were sold, which shot up to 294,000 units in January 2023 and 395,000 units in February 2023, with a value of ₹9.7 crore, ₹12.8 crore and ₹29 crore, respectively.
The uptick in sales can be linked to the rising flu cases in the country. According to the data available on the Integrated Disease Surveillance Programme-Integrated Health Information Platform (IDSP-IHIP) under the Ministry of Health and Family Welfare, a total of 3,038 laboratory-confirmed cases of various subtypes of influenza, including H1N1 and H3N2, had been reported till March 9, 2023, by the states.
Diese Geschichte stammt aus der April 16, 2023-Ausgabe von Business Today India.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der April 16, 2023-Ausgabe von Business Today India.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
DRIVING POSITIVE CHANGE
The Indian cement industry is making significant strides to shift to a more sustainable future. However, challenges such as high infrastructure costs remain
BUILDING SMARTER MANUFACTURING
The intersection of IT, manufacturing operations technology, and sustainability in Industry 4.0 represents a once-in-a-generation opportunity
SPEED & CONVENIENCE
QUICK COMMERCE PLAYERS SUCH AS BLINKIT, INSTAMART, AND ZEPTO ARE RESHAPING THE INDIAN RETAIL LANDSCAPE WITH ULTRA-FAST DELIVERIES, ALTERING THE WAY INDIANS SHOP. HOWEVER, THE COMPETITION IS FIERCE WITH EVERYONE VYING FOR DOMINANCE
SPACE VISION
The government will focus on R&D and ambitious missions, such as human spaceflight, while operational responsibilities increasingly transition to the private sector
NEW WORLD ORDER
Four disruptions-urbanisation, technological change, demographic shifts, and global connectivity-are converging to create a new world order
SIGNS OF SPRING
With diplomatic relations between India and China showing signs of a thaw, will trade and investments look up? Officials have indicated that India will not ease FDI norms for Chinese firms just now, but will 2025 change this status quo?
BUILDING TOMORROW'S CARE TODAY
The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape
BIG SHOTS
GIVEN THAT MORE THAN 40% OF INDIAN ADULTS ARE STRUGGLING WITH OBESITY AND DIABETES, AFFORDABLE WEIGHT-LOSS DRUGS ARE EXPECTED TO SIGNIFICANTLY DISRUPT THE PHARMACEUTICAL LANDSCAPE IN THE COUNTRY THIS YEAR. AND, THE WEIGHT MANAGEMENT MARKET COULD REACH ₹3.99 LAKH CRORE BY 2032, GROWING AT A CAGR OF MORE THAN 9%
THE END OF AMERICAN FINANCIAL EXCEPTIONALISM
As the dollar cycle reverses and Asia's rise continues, Indian growth will accelerate
HOW TO ADAPT TO EXTREME HEAT
India is vulnerable to extreme heat and yet unprepared. But various initiatives provide a glimpse of what is possible when collaboration and ingenuity come together
